SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : JMED - Jones Pharma (specialty pharmaceutical mfr) -- Ignore unavailable to you. Want to Upgrade?

To: Mikeh who wrote (229)7/19/1999 2:43:00 PM
From: babette spatz  Read Replies (1) | Respond to of 268
 
I was away fellows! Yes--I'm happier than before. Stock finally moved upwards. The split is a good thing in my eyes. You might understand that I expect, and generally am successful in at least 15% gain annually in my investments. I now have a 15% gain over the two years I have owned JMED. Hoping for momentum. Also it may be obvious that this company does not grow solely on acquisitions as we all know that inertia set in on that front!


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News